Adlai Nortye Ltd. Sponsored ADR (ANL) vs Entera Bio Ltd. (ENTX)

Adlai Nortye Ltd. Sponsored ADR and Entera Bio Ltd. are both Biotechnology companies. Adlai Nortye Ltd. Sponsored ADR and Entera Bio Ltd. are of similar size ($562.6M and $530.5M). Across the 7 metrics below, Adlai Nortye Ltd. Sponsored ADR leads on 6 and Entera Bio Ltd. on 1.

Valuation

Metric ANL ENTX Biotechnology median
P/E — n/m 10.64
P/S — 694.55 9.59
P/B n/m 21.32 2.15
Price to free cash flow n/m n/m 26.07
EV/EBITDA n/m n/m 0.65
EV/Sales n/m 629.36 9.45
Earnings yield — (11.40%) (34.69%)
Free cash flow yield 0.00% (7.10%) (24.02%)

Profitability

Metric ANL ENTX Biotechnology median
Gross margin — 0.00% 65.59%
Operating margin — 0.00% 0.00%
Net margin — 0.00% 0.00%
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity 0.00% (138.92%) (51.96%)
Return on assets 0.00% (87.02%) (46.06%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric ANL ENTX Biotechnology median
Revenue growth (TTM) — 66.42% 4.59%
EPS growth (last fiscal year) 31.48% 0.00% 29.88%
Revenue growth, 5-year CAGR — (29.19%) 9.75%
Net income growth, 5-year CAGR — 0.00% 0.00%

Health

Metric ANL ENTX Biotechnology median
Debt to equity 0.12 0.00 0.00
Current ratio 9.55 8.98 4.86
Net debt to EBITDA (0.05) 1.29 1.01

Dividend

Metric ANL ENTX Biotechnology median
Dividend yield — — 0.38%
Payout ratio — — —

Size

Metric ANL ENTX Biotechnology median
Market cap 562.63m 530.46m 174.29m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack